Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury

Yoko Ito, Tomoko Betsuyaku, Katsura Nagai, Yasuyuki Nasuhara, Masaharu Nishimura

研究成果: Article

24 引用 (Scopus)

抄録

Vascular endothelial growth factor (VEGF) is a survival factor in endothelial cells and a promoter of angiogenesis that reportedly plays a pivotal role protecting against injury. In aged humans and animals, lung injuries are generally more serious and cause higher mortality. We thus hypothesized that the expression of VEGF and its related molecules in the lung declines with age. In this study, we first examined the expression of VEGF family (VEGF-A, -B, -C and -D), VEGF-A isoforms (VEGF120, 164, 188), and VEGF-specific receptors (VEGFR-1: Flt-1; VEGFR-2: Flk-1 and VEGFR-3: Flt-4) by quantitative RT-PCR in lungs from young and old mice. Expression of all these except for VEGF-D was significantly lower in old mice than in young mice. We then subjected young and old mice to lipopolysaccaride (LPS)-induced lung injury. Old animals demonstrated poor survival and prolonged lung inflammation when compared with young counterparts. At 24 and 72 h after intratracheal LPS administration, expression of the examined factors was down-regulated in the lungs irrespective of age. In conclusion, pulmonary expression of the VEGF family and their receptors declines with age, and is further down-regulated in LPS-induced lung injury, although the mechanism of age- and/or injury-related down-regulation of VEGF remains unknown.

元の言語English
ページ(範囲)315-323
ページ数9
ジャーナルExperimental Gerontology
40
発行部数4
DOI
出版物ステータスPublished - 2005 4
外部発表Yes

Fingerprint

Lung Injury
Vascular Endothelial Growth Factor A
Lipopolysaccharides
Lung
Vascular Endothelial Growth Factor Receptor-3
Vascular Endothelial Growth Factor B
Vascular Endothelial Growth Factor D
Animals
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factor Receptor-2
Vascular Endothelial Growth Factor Receptor
Survival
Wounds and Injuries
Endothelial cells
Pneumonia
Protein Isoforms
Down-Regulation
Endothelial Cells
Polymerase Chain Reaction
Mortality

ASJC Scopus subject areas

  • Ageing
  • Medicine(all)

これを引用

Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. / Ito, Yoko; Betsuyaku, Tomoko; Nagai, Katsura; Nasuhara, Yasuyuki; Nishimura, Masaharu.

:: Experimental Gerontology, 巻 40, 番号 4, 04.2005, p. 315-323.

研究成果: Article

Ito, Yoko ; Betsuyaku, Tomoko ; Nagai, Katsura ; Nasuhara, Yasuyuki ; Nishimura, Masaharu. / Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. :: Experimental Gerontology. 2005 ; 巻 40, 番号 4. pp. 315-323.
@article{0f2ff7b23db746beba5043a7cef4b52b,
title = "Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury",
abstract = "Vascular endothelial growth factor (VEGF) is a survival factor in endothelial cells and a promoter of angiogenesis that reportedly plays a pivotal role protecting against injury. In aged humans and animals, lung injuries are generally more serious and cause higher mortality. We thus hypothesized that the expression of VEGF and its related molecules in the lung declines with age. In this study, we first examined the expression of VEGF family (VEGF-A, -B, -C and -D), VEGF-A isoforms (VEGF120, 164, 188), and VEGF-specific receptors (VEGFR-1: Flt-1; VEGFR-2: Flk-1 and VEGFR-3: Flt-4) by quantitative RT-PCR in lungs from young and old mice. Expression of all these except for VEGF-D was significantly lower in old mice than in young mice. We then subjected young and old mice to lipopolysaccaride (LPS)-induced lung injury. Old animals demonstrated poor survival and prolonged lung inflammation when compared with young counterparts. At 24 and 72 h after intratracheal LPS administration, expression of the examined factors was down-regulated in the lungs irrespective of age. In conclusion, pulmonary expression of the VEGF family and their receptors declines with age, and is further down-regulated in LPS-induced lung injury, although the mechanism of age- and/or injury-related down-regulation of VEGF remains unknown.",
keywords = "Acute lung injury, Aging, LPS, VEGF, VEGF receptors, VEGF-A isoforms",
author = "Yoko Ito and Tomoko Betsuyaku and Katsura Nagai and Yasuyuki Nasuhara and Masaharu Nishimura",
year = "2005",
month = "4",
doi = "10.1016/j.exger.2005.01.009",
language = "English",
volume = "40",
pages = "315--323",
journal = "Experimental Gerontology",
issn = "0531-5565",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury

AU - Ito, Yoko

AU - Betsuyaku, Tomoko

AU - Nagai, Katsura

AU - Nasuhara, Yasuyuki

AU - Nishimura, Masaharu

PY - 2005/4

Y1 - 2005/4

N2 - Vascular endothelial growth factor (VEGF) is a survival factor in endothelial cells and a promoter of angiogenesis that reportedly plays a pivotal role protecting against injury. In aged humans and animals, lung injuries are generally more serious and cause higher mortality. We thus hypothesized that the expression of VEGF and its related molecules in the lung declines with age. In this study, we first examined the expression of VEGF family (VEGF-A, -B, -C and -D), VEGF-A isoforms (VEGF120, 164, 188), and VEGF-specific receptors (VEGFR-1: Flt-1; VEGFR-2: Flk-1 and VEGFR-3: Flt-4) by quantitative RT-PCR in lungs from young and old mice. Expression of all these except for VEGF-D was significantly lower in old mice than in young mice. We then subjected young and old mice to lipopolysaccaride (LPS)-induced lung injury. Old animals demonstrated poor survival and prolonged lung inflammation when compared with young counterparts. At 24 and 72 h after intratracheal LPS administration, expression of the examined factors was down-regulated in the lungs irrespective of age. In conclusion, pulmonary expression of the VEGF family and their receptors declines with age, and is further down-regulated in LPS-induced lung injury, although the mechanism of age- and/or injury-related down-regulation of VEGF remains unknown.

AB - Vascular endothelial growth factor (VEGF) is a survival factor in endothelial cells and a promoter of angiogenesis that reportedly plays a pivotal role protecting against injury. In aged humans and animals, lung injuries are generally more serious and cause higher mortality. We thus hypothesized that the expression of VEGF and its related molecules in the lung declines with age. In this study, we first examined the expression of VEGF family (VEGF-A, -B, -C and -D), VEGF-A isoforms (VEGF120, 164, 188), and VEGF-specific receptors (VEGFR-1: Flt-1; VEGFR-2: Flk-1 and VEGFR-3: Flt-4) by quantitative RT-PCR in lungs from young and old mice. Expression of all these except for VEGF-D was significantly lower in old mice than in young mice. We then subjected young and old mice to lipopolysaccaride (LPS)-induced lung injury. Old animals demonstrated poor survival and prolonged lung inflammation when compared with young counterparts. At 24 and 72 h after intratracheal LPS administration, expression of the examined factors was down-regulated in the lungs irrespective of age. In conclusion, pulmonary expression of the VEGF family and their receptors declines with age, and is further down-regulated in LPS-induced lung injury, although the mechanism of age- and/or injury-related down-regulation of VEGF remains unknown.

KW - Acute lung injury

KW - Aging

KW - LPS

KW - VEGF

KW - VEGF receptors

KW - VEGF-A isoforms

UR - http://www.scopus.com/inward/record.url?scp=16844368855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16844368855&partnerID=8YFLogxK

U2 - 10.1016/j.exger.2005.01.009

DO - 10.1016/j.exger.2005.01.009

M3 - Article

C2 - 15820612

AN - SCOPUS:16844368855

VL - 40

SP - 315

EP - 323

JO - Experimental Gerontology

JF - Experimental Gerontology

SN - 0531-5565

IS - 4

ER -